Unichem Laboratories Limited (NSE:UNICHEMLAB)
617.15
-23.20 (-3.62%)
Apr 25, 2025, 3:30 PM IST
Unichem Laboratories Revenue
Unichem Laboratories had revenue of 5.33B INR in the quarter ending December 31, 2024, with 22.72% growth. This brings the company's revenue in the last twelve months to 19.03B, up 13.60% year-over-year. In the fiscal year ending March 31, 2024, Unichem Laboratories had annual revenue of 17.05B with 26.94% growth.
Revenue (ttm)
19.03B
Revenue Growth
+13.60%
P/S Ratio
2.29
Revenue / Employee
6.62M
Employees
2,875
Market Cap
43.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 17.05B | 3.62B | 26.94% |
Mar 31, 2023 | 13.43B | 731.90M | 5.76% |
Mar 31, 2022 | 12.70B | 346.97M | 2.81% |
Mar 31, 2021 | 12.35B | 1.31B | 11.91% |
Mar 31, 2020 | 11.04B | -763.34M | -6.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Unichem Laboratories News
- 5 weeks ago - Unichem Laboratories shares rise 2.35% as API plant expansion boosts production capacity - Business Upturn
- 5 weeks ago - Unichem Laboratories completes Phase I expansion of API plant at Pithampur with Rs 200 crore investment - Business Upturn
- 2 months ago - Unichem Laboratories Q3 results: Revenue rises 14.4% YoY to Rs 533 crore, Net profit falls 21% YoY - Business Upturn